Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
37752
CAS Number:
183133-96-2
Cabazitaxel
Purity:
≥ 98% (HPLC)
Synonym(s):
XRP 6258
Documents
$118.08 /25MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Cabazitaxel is a potent chemotherapeutic agent primarily used in the treatment of metastatic castration-resistant prostate cancer. This compound, a semi-synthetic derivative of paclitaxel, exhibits remarkable efficacy by inhibiting microtubule depolymerization, thereby disrupting cancer cell division. Its unique structure allows for enhanced activity against taxane-resistant tumors, making it a valuable option for patients who have not responded to other therapies. Cabazitaxel is often utilized in combination with other treatments, enhancing overall therapeutic outcomes and providing a critical lifeline for patients facing advanced stages of prostate cancer.

In addition to its primary application in oncology, Cabazitaxel is being explored for potential uses in other malignancies, showcasing its versatility in cancer treatment. Researchers are investigating its effects in combination therapies and its role in overcoming drug resistance, which could lead to improved patient outcomes. With its ability to target and inhibit cancer cell proliferation effectively, Cabazitaxel stands out as a vital compound in the ongoing fight against cancer, offering hope and improved quality of life for patients.

Synonyms
XRP 6258
CAS Number
183133-96-2
Purity
≥ 98% (HPLC)
Molecular Formula
C45H57NO14
Molecular Weight
835.94
MDL Number
MFCD18827611
PubChem ID
21348140
Melting Point
180 ?C
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
General Information
Synonyms
XRP 6258
CAS Number
183133-96-2
Purity
≥ 98% (HPLC)
Molecular Formula
C45H57NO14
Molecular Weight
835.94
MDL Number
MFCD18827611
PubChem ID
21348140
Melting Point
180 ?C
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Cabazitaxel is widely utilized in research focused on:

  • Cancer Treatment: Primarily used as a chemotherapy agent for treating metastatic castration-resistant prostate cancer, offering an alternative for patients who have progressed after other treatments.
  • Drug Formulation: Employed in the development of injectable formulations, enhancing the solubility and bioavailability of poorly soluble drugs, which is crucial in pharmaceutical development.
  • Combination Therapies: Investigated in combination with other anticancer drugs to improve efficacy and reduce resistance, providing a strategic approach in oncology research.
  • Clinical Trials: Frequently featured in clinical studies to evaluate its effectiveness and safety, contributing to the advancement of cancer treatment protocols.
  • Pharmacokinetics Research: Used to study drug metabolism and distribution, helping researchers understand how the drug behaves in the body, which is essential for optimizing treatment regimens.

Citations